Clinical Trial Update: Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

This clinical trial update reports the withdrawal of a Phase 2 study examining sequential partial liver transplantation followed by bone marrow transplantation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrolamellar Hepatocellular Carcinoma
• Hepatocellular Carcinoma

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Fibrolamellar Hepatocellular Carcinoma, Hepatocellular Carcinoma (Fibrolamellar Variant) | Phase 2 | Status: WITHDRAWN